A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers

被引:11
作者
Kim, Seungyeon [1 ,2 ]
Yu, Yun Mi [3 ,4 ,5 ]
You, Myoungsoon [6 ]
Jeong, Kyeong Hye [7 ]
Lee, Euni [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea
[3] Yonsei Univ, Coll Pharm, Dept Pharm, Incheon 21983, South Korea
[4] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon 21983, South Korea
[5] Yonsei Univ, Coll Med, Dept Pharmaceut Med & Regulatory Sci, Incheon 21983, South Korea
[6] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul 08826, South Korea
[7] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
关键词
Pharmacovigilance; Adverse drug reaction; Consumer; Spontaneous reporting; Attitude; Awareness; Self-efficacy; SOCIAL MEDIA; PHARMACOVIGILANCE; BEHAVIOR; SAFETY; SYMPTOMS; MOTIVES;
D O I
10.1186/s12889-020-09635-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundSpontaneous reporting (SR) of adverse drug reactions (ADRs) from patients can be considered as a valuable activity providing both objective and subjective data. However, improving the rate of under-reporting has been a major challenge to ensure successful operation of the SR system. This study aimed to assess knowledge, attitude, and intent to report ADRs and explore the factors contributing to consumers' reporting intent in South Korea.MethodsSelf-administered questionnaire was collected from a sex-, age-, and regionally stratified nationwide convenience sample of consumers using a commercial panel in December 2018. Univariate and multivariate logistic regression analyses were used to explore the factors contributing to the intent to report ADRs by consumers.ResultsA total of 1000 respondents were enrolled in the survey; 50.9% were males and the mean age was 44.4 (standard deviation, 13.3) years. While less than 15% of the respondents were aware of the SR system and even fewer (3.4%) had actual experience of SR, however, 59.2% expressed their intent to report ADRs. The positive attitude (adjusted odds ratio [aOR] 3.972, p<0.001), awareness of the SR system (aOR 2.102, p<0.01), self-efficacy for SR (aOR 1.956, p<0.001), and experiences related to ADR counselling with healthcare professionals (OR 2.318, p<0.001) are the significant factors contributing to reporting intent.ConclusionsFindings of this study highlight the need for increasing the awareness of the SR system among consumers and empowering them to report ADRs by themselves, which would ultimately improve the drug-safety environment.
引用
收藏
页数:11
相关论文
共 48 条
[1]   Consumer Reporting of Adverse Drug Reactions A Retrospective Analysis of the Danish Adverse Drug Reaction Database from 2004 to 2006 [J].
Aagaard, Lise ;
Nielse, Lars Hougaard ;
Hansen, Ebba Holme .
DRUG SAFETY, 2009, 32 (11) :1067-1074
[2]   Factors affecting patient reporting of adverse drug reactions: a systematic review [J].
Al Dweik, Rania ;
Stacey, Dawn ;
Kohen, Dafna ;
Yaya, Sanni .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) :875-883
[3]   Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme [J].
Anderson, Claire ;
Gifford, Alison ;
Avery, Anthony ;
Fortnum, Heather ;
Murphy, Elizabeth ;
Krska, Janet ;
Bond, Christine .
HEALTH EXPECTATIONS, 2012, 15 (04) :433-440
[4]   The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective [J].
Anderson, Claire ;
Krska, Janet ;
Murphy, Elizabeth ;
Avery, Anthony .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (05) :806-822
[5]  
[Anonymous], TILL PAN INTR
[6]  
[Anonymous], **NON-TRADITIONAL**
[7]   The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review [J].
Atkinson, Thomas M. ;
Ryan, Sean J. ;
Bennett, Antonia V. ;
Stover, Angela M. ;
Saracino, Rebecca M. ;
Rogak, Lauren J. ;
Jewell, Sarah T. ;
Matsoukas, Konstantina ;
Li, Yuelin ;
Basch, Ethan .
SUPPORTIVE CARE IN CANCER, 2016, 24 (08) :3669-3676
[8]   Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys [J].
Avery, A. J. ;
Anderson, C. ;
Bond, C. M. ;
Fortnum, H. ;
Gifford, A. ;
Hannaford, P. C. ;
Hazell, L. ;
Krska, J. ;
Lee, A. J. ;
McLernon, D. J. ;
Murphy, E. ;
Shakir, S. ;
Watson, M. C. .
HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (20) :1-+
[9]  
Bahk Chi Y, 2015, Pharmaceut Med, V29, P331
[10]   Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance [J].
Banerjee, Anjan K. ;
Okun, Sally ;
Edwards, I. Ralph ;
Wicks, Paul ;
Smith, Meredith Y. ;
Mayall, Stephen J. ;
Flamion, Bruno ;
Cleeland, Charles ;
Basch, Ethan .
DRUG SAFETY, 2013, 36 (12) :1129-1149